Pathogenesis of Muscular Dystrophies

肌营养不良症的发病机制

• 批准号: 8297161
• 负责人: Jeffrey Boone Miller
• 金额: $ 39.41万
• 依托单位: BOSTON BIOMEDICAL RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-05-01 至 2013-02-11
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8297161
• 关键词: Acetylation; Acetyltransferase; Adhalin; Bax protein; Binding; Biochemical; Biological; Biotechnology; Cell Death; Cells; Cessation of life; Childhood; Clinical Trials; Complex; Cytosol; Deacetylase; Disease; Disease model; Future; G22P1 gene; Goals; Human; Knockout Mice; Knowledge; Ku70 protein; Laminin; Lead; Libraries; Limb-Girdle Muscular Dystrophies; Longevity; Lysine; Mediating; Mitochondria; Molecular; Mus; Muscle; Muscle Cells; Muscle Fibers; Muscular Dystrophies; Mutation; Myoblasts; Nuclear; Outcome; Pathogenesis; Pathology; Pathway interactions; Patients; Pharmacologic Substance; Research Design; Signal Transduction; System; Techniques; Testing; Therapeutic; Work; congenital muscular dystrophy; design; disorder control; gamma Sarcoglycan; human disease; improved; interest; neuromuscular function; novel therapeutics; research and development; research study; response; therapeutic target; therapy development

DESCRIPTION (provided by applicant): The goals of our studies are to (i) determine pathogenetic mechanisms and (ii) identify new therapeutic strategies for a group of severe muscular dystrophies. We have found that aberrant activation of cell death - mediated by the pro-death protein Bax and its cytosolic binding partner Ku70 - appears to be a pathogenetic mechanism in at least three human muscular dystrophies: Congenital Muscular Dystrophy Type 1A (MDC1A, mutations of laminin- alpha2); Limb-girdle Muscular Dystrophy Type 2D (LGMD2D, mutations of alpha-sarcoglycan); and LGMD2C (mutations of gamma-sarcoglycan). For each of these muscular dystrophies, a key step in pathogenesis appears to be aberrantly increased acetylation of Ku70, which in turn leads to induction of Bax-mediated cell death. We now propose to identify the mechanisms that underlie this disease-induced dysregulation of the Ku70/Bax pathway. One set of experiments will identify the deacetylase and acetyltransferase mechanisms that regulate Ku70 function. A second set of experiments will determine if restoring normal Ku70 acetylation will ameliorate pathology in disease models. The studies will analyze both mouse disease models and cells from our extensive library of myogenic cells from human patients. The patient cells provide a particularly favorable system to study mechanisms of pathogenesis, because we find that myotubes formed in culture from human MDC1A, LGMD2C, and LGM2D patient myoblasts, but not normal myoblasts, spontaneously undergo cell death. Under Specific Aim 1, we will identify Ku70 deacetylase and acetyltransferase mechanisms in normal and diseased muscle cells. These studies will test our hypothesis that aberrant function of Ku70 deacetylases and/or acetyltransferases causes muscle pathology. Under Specific Aim 2, we will determine if restoring normal Ku70 acetylation ameliorates pathology. These studies will test our hypothesis that restoring a healthy low level of Ku70 acetylation will inhibit cell dath and lessen pathology in disease models. Our studies are designed to identify pathogenetic mechanisms that are common to multiple muscular dystrophies. From our results, we expect to identify potential therapeutic strategies that could be effective for multiple diseases. PUBLIC HEALTH RELEVANCE: The goals of our experiments are to identify pathogenetic mechanisms and potential new therapeutic strategies for a group of severe childhood muscular dystrophies (MDC1A, LGMD2C, LGMD2D). Each of these childhood diseases is severely debilitating and treatments are lacking, so new therapies are critically needed.

描述（由申请人提供）：我们研究的目标是(i)确定发病机制和（ii）确定一组严重肌营养不良症的新治疗策略。我们发现，由死亡前蛋白Bax及其细胞质结合伙伴Ku70介导的细胞死亡异常激活似乎是至少三种人类肌营养不良症的发病机制：1A型先天性肌营养不良症（MDC1A，层粘连蛋白α 2突变）；2型肢体肌营养不良症（LGMD2D， α -肌聚糖突变）；和LGMD2C （γ -肌聚糖突变）。对于每一种肌营养不良，发病的关键步骤似乎是Ku70乙酰化异常增加，这反过来导致诱导bax介导的细胞死亡。我们现在建议确定这种疾病诱导的Ku70/Bax通路失调的机制。一组实验将确定调节Ku70功能的去乙酰化酶和乙酰转移酶机制。第二组实验将确定恢复正常的Ku70乙酰化是否会改善疾病模型中的病理。这些研究将分析小鼠疾病模型和我们广泛的人类患者肌源性细胞文库中的细胞。患者细胞为研究发病机制提供了一个特别有利的系统，因为我们发现从人MDC1A、LGMD2C和LGM2D患者成肌细胞培养形成的肌管，而不是正常的成肌细胞，会自发地发生细胞死亡。在Specific Aim 1下，我们将确定正常和病变肌肉细胞中Ku70去乙酰化酶和乙酰转移酶的机制。这些研究将验证我们的假设，即Ku70去乙酰化酶和/或乙酰转移酶的异常功能导致肌肉病理。在Specific Aim 2下，我们将确定恢复正常的Ku70乙酰化是否能改善病理。这些研究将验证我们的假设，即恢复健康的低水平Ku70乙酰化将抑制细胞死亡并减轻疾病模型中的病理。我们的研究旨在确定多发性肌肉萎缩症常见的发病机制。从我们的研究结果中，我们期望找到对多种疾病有效的潜在治疗策略。